Skip to content
quinupristin

Structure via PubChem · Public domain (PubChem)

EntityQ7272542· pop 6· linked from 117 articles

quinupristin

Sign in to save

Also known as RP-57669

Quinupristin is a streptogramin B antibiotic, used in combination with dalfopristin under the trade name Synercid. It has activity against Gram-positive and atypical bacteria but not Gram-negative bacteria. It inhibits bacterial protein synthesis. The combination of quinupristin and dalfopristin is not active against Enterococcus faecalis and needs to be given in combination with other antibacterials for mixed infections that involve Gram-negative organisms. Category:Antibiotics

In the Vinony graph

Within Vinony's link graph, quinupristin is referenced by 117 other articles, and connects out to International Standard Book Number, antibiotic and chemical formula.

It sits within the topics Antibiotics, Chemical pages without DrugBank identifier and Drugs missing an ATC code.

Its subject is documented across 6 Wikipedia language editions.

Chemical data

Formula
C53H67N9O10S
Molecular weight
1022.2 g/mol
IUPAC name
N-[(3S,6S,12R,15S,16R,19S,22S,25R)-25-[[(3S)-1-azabicyclo[2.2.2]octan-3-yl]sulfanylmethyl]-3-[[4-(dimethylamino)phenyl]methyl]-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide
SMILES
CC[C@@H]1C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)N3C[C@H](C(=O)C[C@H]3C(=O)N[C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CS[C@@H]6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C
InChIKey
WTHRRGMBUAHGNI-LCYNINFDSA-N
XLogP
4.2
Polar surface area
257 Ų
H-bond donors
4
H-bond acceptors
14
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
1999
Admin. routes
parenteral
Indications
osteomyelitis

via ChEMBL · EBI

Research

1,312 papers

via PubMed

Wikidata facts

Subclass of
streptogramins
Mass
1021.473
Has use
medication
Show 5 more facts
chemical formula
C₅₃H₆₇N₉O₁₀S
isomeric SMILES
CC[C@@H]1C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)N3C[C@H](C(=O)C[C@H]3C(=O)N[C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CS[C@@H]6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C
canonical SMILES
CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CC(C(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CSC6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C
medical condition treated
staphylococcal infection
subject has role
antibiotic
Sources (2)

via Wikidata · CC0

~2 min read

Encyclopedic overview

1 sections
Contents
  • References

{{Drugbox | IUPAC_name = N-{(6R,9S,10R,13S,15aS,18R,22S,24aS)-18- {[(3S)-1-azabicyclo[2.2.2]oct-3-ylthio]methyl}-22-[4-(dimethylamino)benzyl]- 6-ethyl-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyldocosahydro-12H- pyrido[2,1-f]pyrrolo-[2,1-l][1,4,7,10,13,16] oxapentaazacyclononadecin-9-yl}-3- hydroxypyridine-2-carboxamide | image = Quinupristin.png | image_class = skin-invert-image | CAS_number = 120138-50-3 | UNII_Ref = | UNII = 23OW28RS7P | ATC_prefix = | ATC_suffix = | PubChem = 5388937 | DrugBank = | ChEMBL = 1200649 | ChemSpiderID = 4470884 | smiles = CC[C@@H]1C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)N3C[C@H](C(=O)C[C@H]3C(=O)N[C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CS[C@@H]6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C | StdInChI = 1S/C53H67N9O10S/c1-6-37-50(68)61-23-11-14-38(61)51(69)59(5)40(26-32-16-18-36(19-17-32)58(3)4)52(70)62-28-35(30-73-43-29-60-24-20-33(43)21-25-60)42(64)27-39(62)47(65)57-45(34-12-8-7-9-13-34)53(71)72-31(2)44(48(66)55-37)56-49(67)46-41(63)15-10-22-54-46/h7-10,12-13,15-19,22,31,33,35,37-40,43-45,63H,6,11,14,20-21,23-30H2,1-5H3,(H,55,66)(H,56,67)(H,57,65)/t31-,35+,37-,38+,39+,40+,43-,44+,45+/m1/s1 | StdInChIKey = WTHRRGMBUAHGNI-LCYNINFDSA-N | C=53|H=67|N=9|O=10|S=1 | bioavailability = | protein_bound = | metabolism = | elimination_half-life = 3.1 hours | excretion = | pregnancy_AU = | pregnancy_US = | pregnancy_category= | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = }}

Quinupristin is a streptogramin B antibiotic, used in combination with dalfopristin under the trade name Synercid. It has activity against Gram-positive and atypical bacteria but not Gram-negative bacteria. It inhibits bacterial protein synthesis. The combination of quinupristin and dalfopristin is not active against Enterococcus faecalis and needs to be given in combination with other antibacterials for mixed infections that involve Gram-negative organisms. Category:Antibiotics

Excerpted from Wikipedia’s “quinupristin” article, available under the CC BY-SA 4.0 licence.

Available in 6 languages

via Wikidata sitelinks · CC0

Connections

Categories